• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷脂酰肌醇3激酶有助于与肝细胞生长因子诱导的细胞散射相关的Erk1/Erk2丝裂原活化蛋白激酶激活。

Phosphatidylinositol 3-kinase contributes to Erk1/Erk2 MAP kinase activation associated with hepatocyte growth factor-induced cell scattering.

作者信息

Sipeki S, Bander E, Buday L, Farkas G, Bácsy E, Ways D K, Faragó A

机构信息

Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University of Medicine, Budapest, Hungary.

出版信息

Cell Signal. 1999 Dec;11(12):885-90. doi: 10.1016/s0898-6568(99)00060-1.

DOI:10.1016/s0898-6568(99)00060-1
PMID:10659996
Abstract

MAP kinase cascade-dependent responses were investigated during scattering of HepG2 human hepatoma cells stimulated by HGF or phorbol ester. Inhibition of phosphatidylinositol 3-kinase with LY294002 prevented completely the dissociation of cells. Inhibition of MAP kinase kinase (MEK) with PD98059 prevented the development of characteristic morphological changes associated with cell migration. EGF, which failed to induce cell scattering, caused a short-term increase in the phosphorylation of Erk1/Erk2 MAP kinases. On the contrary, HGF or phorbol ester stimulated the phosphorylation of MAP kinases for a long time. Experiments performed with LY294002 indicated that phosphatidylinositol 3-kinase contributed to the HGF-stimulated phosphorylation of Erk1/Erk2. This finding was confirmed by the demonstration that the MAP kinase cascade-dependent expression of a high-Mr (>300 kDa) protein pair appearing in the course of cell scattering was inhibited by LY294002 in HGF-induced cells but was not inhibited in phorbol ester-treated cells.

摘要

在HGF或佛波酯刺激HepG2人肝癌细胞散射过程中,研究了丝裂原活化蛋白激酶(MAP)激酶级联反应依赖性应答。用LY294002抑制磷脂酰肌醇3激酶可完全阻止细胞解离。用PD98059抑制MAP激酶激酶(MEK)可阻止与细胞迁移相关的特征性形态变化的发展。未能诱导细胞散射的表皮生长因子(EGF)导致Erk1/Erk2 MAP激酶磷酸化短期增加。相反,HGF或佛波酯可长时间刺激MAP激酶磷酸化。用LY294002进行的实验表明,磷脂酰肌醇3激酶促进了HGF刺激的Erk1/Erk2磷酸化。这一发现通过以下证明得到证实:在细胞散射过程中出现的高分子量(>300 kDa)蛋白对的MAP激酶级联反应依赖性表达在HGF诱导的细胞中被LY294002抑制,但在佛波酯处理的细胞中未被抑制。

相似文献

1
Phosphatidylinositol 3-kinase contributes to Erk1/Erk2 MAP kinase activation associated with hepatocyte growth factor-induced cell scattering.磷脂酰肌醇3激酶有助于与肝细胞生长因子诱导的细胞散射相关的Erk1/Erk2丝裂原活化蛋白激酶激活。
Cell Signal. 1999 Dec;11(12):885-90. doi: 10.1016/s0898-6568(99)00060-1.
2
Protein kinase C decreases the hepatocyte growth factor-induced activation of Erk1/Erk2 MAP kinases.蛋白激酶C可降低肝细胞生长因子诱导的Erk1/Erk2丝裂原活化蛋白激酶的激活。
Cell Signal. 2000 Aug;12(8):549-55. doi: 10.1016/s0898-6568(00)00105-4.
3
ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.ERK信号通路参与了由佛波酯(TPA)和柴胡皂苷a触发的p15INK4b/p16INK4a表达及HepG2细胞生长抑制过程。
Oncogene. 2003 Feb 20;22(7):955-63. doi: 10.1038/sj.onc.1206237.
4
Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.葡萄籽提取物抑制表皮生长因子(EGF)诱导的和组成型激活的促有丝分裂信号传导,但激活人前列腺癌DU145细胞中的JNK:在抗增殖和凋亡中的可能作用。
Oncogene. 2003 Mar 6;22(9):1302-16. doi: 10.1038/sj.onc.1206265.
5
Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.胰岛素样生长因子I介导的对雷帕霉素诱导的细胞凋亡的保护作用独立于Ras-Erk1-Erk2和磷脂酰肌醇3'-激酶-Akt信号通路。
Cancer Res. 2003 Jan 15;63(2):364-74.
6
Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway.血小板因子4通过细胞外信号调节激酶途径而非磷脂酰肌醇3激酶途径抑制成纤维细胞生长因子2诱导的内皮细胞增殖。
Blood. 2002 Nov 1;100(9):3087-94. doi: 10.1182/blood.V100.9.3087.
7
Downstream effectors of oncogenic ras in multiple myeloma cells.多发性骨髓瘤细胞中致癌性Ras的下游效应分子。
Blood. 2003 Apr 15;101(8):3126-35. doi: 10.1182/blood-2002-08-2640. Epub 2002 Dec 19.
8
Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells.阿司匹林和NS-398抑制肝细胞生长因子诱导的人肝癌细胞侵袭性。
Hepatology. 2002 May;35(5):1117-24. doi: 10.1053/jhep.2002.32676.
9
Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase.胰岛素样生长因子-I对尿激酶型纤溶酶原激活物的上调作用依赖于磷脂酰肌醇-3激酶和丝裂原活化蛋白激酶激酶。
Cancer Res. 2001 Feb 15;61(4):1367-74.
10
Phorbol ester-induced migration of HepG2 cells is accompanied by intensive stress fibre formation, enhanced integrin expression and transient down-regulation of p21-activated kinase 1.佛波酯诱导的HepG2细胞迁移伴随着强烈的应力纤维形成、整合素表达增强以及p21激活激酶1的瞬时下调。
Cell Signal. 2003 Mar;15(3):307-18. doi: 10.1016/s0898-6568(02)00087-6.

引用本文的文献

1
Genomic instability in congenital lung malformations in children.儿童先天性肺畸形中的基因组不稳定性。
Pediatr Surg Int. 2024 Sep 5;40(1):248. doi: 10.1007/s00383-024-05835-5.
2
Therapeutic potential of tyrosine-protein kinase MET in osteosarcoma.酪氨酸蛋白激酶MET在骨肉瘤中的治疗潜力
Front Mol Biosci. 2024 Mar 26;11:1367331. doi: 10.3389/fmolb.2024.1367331. eCollection 2024.
3
Savolitinib: A Promising Targeting Agent for Cancer.赛沃替尼:一种有前景的癌症靶向药物。
Cancers (Basel). 2023 Sep 25;15(19):4708. doi: 10.3390/cancers15194708.
4
CD44v6+ Hepatocellular Carcinoma Cells Maintain Stemness Properties through Met/cJun/Nanog Signaling.CD44v6+ 肝癌细胞通过Met/cJun/Nanog信号通路维持干性特征
Stem Cells Int. 2022 Nov 7;2022:5853707. doi: 10.1155/2022/5853707. eCollection 2022.
5
Cellular crosstalk during liver regeneration: unity in diversity.肝脏再生过程中的细胞串扰:多样性中的统一性。
Cell Commun Signal. 2022 Aug 8;20(1):117. doi: 10.1186/s12964-022-00918-z.
6
MicroRNAs as the critical regulators of tyrosine kinase inhibitors resistance in lung tumor cells.微小 RNA 作为肺肿瘤细胞中酪氨酸激酶抑制剂耐药性的关键调节因子。
Cell Commun Signal. 2022 Mar 9;20(1):27. doi: 10.1186/s12964-022-00840-4.
7
The Emerging Role of c-Met in Carcinogenesis and Clinical Implications as a Possible Therapeutic Target.c-Met在致癌作用中的新作用及其作为潜在治疗靶点的临床意义
J Oncol. 2022 Jan 13;2022:5179182. doi: 10.1155/2022/5179182. eCollection 2022.
8
Lung Cancer with exon 14 Skipping Mutation: Genetic Feature, Current Treatments, and Future Challenges.具有外显子14跳跃突变的肺癌:遗传特征、当前治疗方法及未来挑战
Lung Cancer (Auckl). 2021 May 20;12:35-50. doi: 10.2147/LCTT.S269307. eCollection 2021.
9
A Systemic Review on the Regulatory Roles of miR-34a in Gastrointestinal Cancer.miR-34a在胃肠道癌中调控作用的系统评价
Onco Targets Ther. 2020 Apr 3;13:2855-2872. doi: 10.2147/OTT.S234549. eCollection 2020.
10
A phase I trial of topotecan plus tivantinib in patients with advanced solid tumors.拓扑替康联合替沃扎尼治疗晚期实体瘤患者的 I 期临床试验。
Cancer Chemother Pharmacol. 2018 Oct;82(4):723-732. doi: 10.1007/s00280-018-3672-y. Epub 2018 Aug 20.